May 11-14, 2026
Hynes Convention CenterBoston, MA Oron Yacoby ZeviChief Scientific Officer at Immunobel TherapeuticsSpeaker
Profile
Oron Yacoby Zeevi is a veteran biotech innovator with 30+ years of leadership in drug discovery and development across multiple therapeutic areas. She led the R&D at NeuroDerm through its landmark $1.1B acquisition, and later served as CSO of NeuroSense Therapeutics. Oron advises emerging biotech companies and investors, and is the inventor behind more than 80 patents and applications.
Agenda Sessions
Immune-Modulating NanoBiologics (INBs): A Novel mRNA-Based Therapeutic Strategy for the treatment of Autoimmune and Autoinflammatory Diseases – A Preclinical Case Study
, 4:00pmView Session